BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31706616)

  • 1. Differences in primary hyperparathyroidism characteristics between children and adolescents.
    Zivaljevic V; Jovanovic M; Diklic A; Zdravkovic V; Djordjevic M; Paunovic I
    J Pediatr Surg; 2020 Aug; 55(8):1660-1662. PubMed ID: 31706616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of age and gender on presentation of symptomatic primary hyperparathyroidism.
    Shah VN; Bhadada SK; Bhansali A; Behera A; Mittal BR; Bhavin V
    J Postgrad Med; 2012; 58(2):107-11. PubMed ID: 22718053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical profile of primary hyperparathyroidism in adolescents and young adults.
    Loh KC; Duh QY; Shoback D; Gee L; Siperstein A; Clark OH
    Clin Endocrinol (Oxf); 1998 Apr; 48(4):435-43. PubMed ID: 9640410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Characteristics of Primary Hyperparathyroidism: 15-Year Experience of 457 Patients in a Single Center in China.
    Lin X; Fan Y; Zhang Z; Yue H
    Front Endocrinol (Lausanne); 2021; 12():602221. PubMed ID: 33716964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical profile of primary hyperparathyroidism from western India: a single center experience.
    Gopal RA; Acharya SV; Bandgar T; Menon PS; Dalvi AN; Shah NS
    J Postgrad Med; 2010; 56(2):79-84. PubMed ID: 20622385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of outcomes for younger and older adult patients undergoing surgery for primary hyperparathyroidism.
    Kandil E; Majid DS; Carson KA; Tufano RP
    Ann Surg Oncol; 2012 Jun; 19(6):1897-901. PubMed ID: 22207049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 10-year retrospective study of primary hyperparathyroidism in children.
    Li CC; Yang C; Wang S; Zhang J; Kong XR; Ouyang J
    Exp Clin Endocrinol Diabetes; 2012 Apr; 120(4):229-33. PubMed ID: 22328111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analyses of risk factors for temporarily inhibited parathyroid hormone secretion of postoperative primary hyperparathyroidism].
    Liu X; Zhao T; Wang JC; Shen H; Wang Q; Xin YH; Wei BB
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 May; 55(5):497-500. PubMed ID: 32842365
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary hyperparathyroidism in adolescents: the same but different.
    Pashtan I; Grogan RH; Kaplan SP; Devon K; Angelos P; Liu D; Kaplan EL
    Pediatr Surg Int; 2013 Mar; 29(3):275-9. PubMed ID: 23184264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRIMARY HYPERPARATHYROIDISM IN THE YOUNG: COMPARISON WITH ADULT PRIMARY HYPERPARATHYROIDISM.
    Mukherjee S; Bhadada SK; Arya AK; Singh P; Sood A; Dahiya D; Ram S; Saikia UN; Behera A
    Endocr Pract; 2018 Dec; 24(12):1051-1056. PubMed ID: 30289299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and associated risk factors of simple renal cysts in primary hyperparathyroidism.
    Sakız D; Sencar ME; Çalapkulu M; Ünsal İÖ; Kızılgül M; Uçan B; Özbek M; Çakal E
    Hormones (Athens); 2023 Mar; 22(1):107-112. PubMed ID: 36319934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary hyperparathyroidism in children and young adults:--a single institution experience.
    Paunovic I; Zivaljevic V; Stojanic R; Kalezic N; Kazic M; Diklic A
    Acta Chir Belg; 2013; 113(1):35-9. PubMed ID: 23550467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spectrum of manifestations of primary hyperparathyroidism in children and adolescents.
    Boro H; Khatiwada S; Alam S; Kubihal S; Dogra V; Malla S; Kumar C
    Pediatr Endocrinol Diabetes Metab; 2022; 28(3):178-187. PubMed ID: 35942826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timely Evaluation and Management of Primary Hyperparathyroidism in Patients With Kidney Stones.
    Perez AA; Schneider DF; Long KL; Pitt SC; Sippel RS
    J Surg Res; 2018 Dec; 232():564-569. PubMed ID: 30463775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics, management, and outcome of primary hyperparathyroidism at a single clinical center from 2005 to 2016.
    Sun B; Guo B; Wu B; Kang J; Deng X; Zhang Z; Fan Y
    Osteoporos Int; 2018 Mar; 29(3):635-642. PubMed ID: 29198075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of 25-hydroxyvitamin D deficiency on perioperative parathyroid hormone kinetics and results in patients with primary hyperparathyroidism.
    Untch BR; Barfield ME; Dar M; Dixit D; Leight GS; Olson JA
    Surgery; 2007 Dec; 142(6):1022-6. PubMed ID: 18063090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative normal level of parathyroid hormone signifies an early and mild form of primary hyperparathyroidism.
    Bergenfelz A; Lindblom P; Lindergård B; Valdemarsson S; Westerdahl J
    World J Surg; 2003 Apr; 27(4):481-5. PubMed ID: 12658497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sporadic primary hyperparathyroidism and stone disease: a comprehensive metabolic evaluation before and after parathyroidectomy.
    Marchini GS; Faria KVM; Torricelli FCM; Monga M; Srougi M; Nahas WC; Mazzucchi E
    BJU Int; 2018 Feb; 121(2):281-288. PubMed ID: 29124877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creation of a "Wisconsin index" nomogram to predict the likelihood of additional hyperfunctioning parathyroid glands during parathyroidectomy.
    Mazeh H; Chen H; Leverson G; Sippel RS
    Ann Surg; 2013 Jan; 257(1):138-41. PubMed ID: 22801087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary hyperparathyroidism: findings from the retrospective evaluation of cases over a 6-year period from a regional UK centre.
    Pappachan JM; Elnaggar MN; Sodi R; Jbeili K; Smith PR; Lahart IM
    Endocrine; 2018 Oct; 62(1):174-181. PubMed ID: 30019307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.